DS-3939a
DS3939-077
Phase 2 small_molecule active
Quick answer
DS-3939a for Metastatic Solid Tumor, Advanced Solid Tumor is a Phase 2 program (small_molecule) at Daiichi Sankyo Europe GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Daiichi Sankyo Europe GmbH
- Indication
- Metastatic Solid Tumor, Advanced Solid Tumor
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active